Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function.

Mullin NP, Gagliardi A, Khoa LTP, Colby D, Hall-Ponsele E, Rowe AJ, Chambers I.

J Mol Biol. 2017 May 19;429(10):1544-1553. doi: 10.1016/j.jmb.2016.12.001. Epub 2016 Dec 6.

2.

Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer.

Hiken JF, McDonald JI, Decker KF, Sanchez C, Hoog J, VanderKraats ND, Jung KL, Akinhanmi M, Rois LE, Ellis MJ, Edwards JR.

Oncogene. 2017 Apr 20;36(16):2319-2327. doi: 10.1038/onc.2016.397. Epub 2016 Nov 21.

3.

The Steroid Hormone 20-Hydroxyecdysone Enhances Gene Transcription through the cAMP Response Element-binding Protein (CREB) Signaling Pathway.

Jing YP, Wang D, Han XL, Dong DJ, Wang JX, Zhao XF.

J Biol Chem. 2016 Jun 10;291(24):12771-85. doi: 10.1074/jbc.M115.706028. Epub 2016 Apr 20.

4.

G9a-mediated methylation of ER╬▒ links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.

Zhang X, Peng D, Xi Y, Yuan C, Sagum CA, Klein BJ, Tanaka K, Wen H, Kutateladze TG, Li W, Bedford MT, Shi X.

Nat Commun. 2016 Mar 10;7:10810. doi: 10.1038/ncomms10810.

5.

Estrogen Signaling Modulates Allergic Inflammation and Contributes to Sex Differences in Asthma.

Keselman A, Heller N.

Front Immunol. 2015 Nov 16;6:568. doi: 10.3389/fimmu.2015.00568. eCollection 2015. Review.

6.

Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.

Helzer KT, Hooper C, Miyamoto S, Alarid ET.

J Mol Endocrinol. 2015 Jun;54(3):R151-67. doi: 10.1530/JME-14-0308. Epub 2015 May 5. Review.

7.

Long-term consequences of estrogens administered in midlife on female cognitive aging.

Daniel JM, Witty CF, Rodgers SP.

Horm Behav. 2015 Aug;74:77-85. doi: 10.1016/j.yhbeh.2015.04.012. Epub 2015 Apr 25. Review.

8.

Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer.

Yoshimaru T, Komatsu M, Miyoshi Y, Honda J, Sasa M, Katagiri T.

Cancer Sci. 2015 May;106(5):550-8. doi: 10.1111/cas.12654. Epub 2015 Apr 1.

9.

A mechanism of global shape-dependent recognition and phosphorylation of filamin by protein kinase A.

Ithychanda SS, Fang X, Mohan ML, Zhu L, Tirupula KC, Naga Prasad SV, Wang YX, Karnik SS, Qin J.

J Biol Chem. 2015 Mar 27;290(13):8527-38. doi: 10.1074/jbc.M114.633446. Epub 2015 Feb 9.

10.

Minireview: Tipping the balance: ligand-independent activation of steroid receptors.

Bennesch MA, Picard D.

Mol Endocrinol. 2015 Mar;29(3):349-63. doi: 10.1210/me.2014-1315. Epub 2015 Jan 27. Review.

11.

Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.

Yoshimaru T, Komatsu M, Tashiro E, Imoto M, Osada H, Miyoshi Y, Honda J, Sasa M, Katagiri T.

Sci Rep. 2014 Dec 8;4:7355. doi: 10.1038/srep07355.

12.

Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.

Honeyman JN, Simon EP, Robine N, Chiaroni-Clarke R, Darcy DG, Lim II, Gleason CE, Murphy JM, Rosenberg BR, Teegan L, Takacs CN, Botero S, Belote R, Germer S, Emde AK, Vacic V, Bhanot U, LaQuaglia MP, Simon SM.

Science. 2014 Feb 28;343(6174):1010-4. doi: 10.1126/science.1249484.

13.

Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer.

Wei C, Cao Y, Yang X, Zheng Z, Guan K, Wang Q, Tai Y, Zhang Y, Ma S, Cao Y, Ge X, Xu C, Li J, Yan H, Ling Y, Song T, Zhu L, Zhang B, Xu Q, Hu C, Bian XW, He X, Zhong H.

Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E601-10. doi: 10.1073/pnas.1316255111. Epub 2014 Jan 21.

14.

Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia.

Shibata S, Rinehart J, Zhang J, Moeckel G, Casta├▒eda-Bueno M, Stiegler AL, Boggon TJ, Gamba G, Lifton RP.

Cell Metab. 2013 Nov 5;18(5):660-71. doi: 10.1016/j.cmet.2013.10.005.

15.

Sex differences in anxiety and depression: role of testosterone.

McHenry J, Carrier N, Hull E, Kabbaj M.

Front Neuroendocrinol. 2014 Jan;35(1):42-57. doi: 10.1016/j.yfrne.2013.09.001. Epub 2013 Sep 24. Review.

16.

Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.

Yoshimaru T, Komatsu M, Matsuo T, Chen YA, Murakami Y, Mizuguchi K, Mizohata E, Inoue T, Akiyama M, Yamaguchi R, Imoto S, Miyano S, Miyoshi Y, Sasa M, Nakamura Y, Katagiri T.

Nat Commun. 2013;4:2443. doi: 10.1038/ncomms3443.

17.

Estrogen synthesis and signaling pathways during aging: from periphery to brain.

Cui J, Shen Y, Li R.

Trends Mol Med. 2013 Mar;19(3):197-209. doi: 10.1016/j.molmed.2012.12.007. Epub 2013 Jan 22. Review.

18.

Cooperating transcription factors mediate the function of estrogen receptor.

Fiorito E, Katika MR, Hurtado A.

Chromosoma. 2013 Mar;122(1-2):1-12. doi: 10.1007/s00412-012-0392-7. Epub 2012 Nov 29. Review.

19.

The role of S6K1 in ER-positive breast cancer.

Holz MK.

Cell Cycle. 2012 Sep 1;11(17):3159-65. doi: 10.4161/cc.21194. Epub 2012 Aug 16.

20.

A role for estrogen receptor phosphorylation in the resistance to tamoxifen.

de Leeuw R, Neefjes J, Michalides R.

Int J Breast Cancer. 2011;2011:232435. doi: 10.4061/2011/232435. Epub 2011 Jul 12.

Supplemental Content

Support Center